Comparison of dual-head coincidence gamma camera FDG imaging with FDG PET in detection of breast cancer and axillary lymph node metastasis

Journal of Nuclear Medicine

Volumn 40, Issue 6, 1999, Pages 1003-1008

  Yutani, Kenji ^a   Tatsumi, Mitsuaki ^a   Shiba, Eiichi ^a   Kusuoka, Hideo ^a   Nishimura, Tsunehiko ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Axillary lymph node metastasis; Breast cancer; Dual head coincidence imaging; Fluorodeoxyglucose; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; PHANTOM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCINTILLATION CAMERA;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CARCINOMA, MEDULLARY; FEMALE; FLUORODEOXYGLUCOSE F18; GAMMA CAMERAS; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PHANTOMS, IMAGING; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033002755     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Harris JR, Lippman ME, Veronesi U, Willett W. Breast cancer (1). N Engl J Med. 1992;327:319-328.
2. Kopans DB. The positive predictive value of mammography. AJR. 1992;158:521-526.
3. Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer. 1980;45:2917-2924.
4. Harris JR, Morrow M, Bonadonna G. Cancer of the breast. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 4th ed. Philadelphia, PA: Lippincott; 1993:1264-1332.
5. Siegel BM, Mayzel KA, Love SM. Level I and II axillary dissection in the treatment of early-stage breast cancer. An analysis of 259 consecutive patients. Arch Surg. 1990;125:1144-1147.
6. Wahl RL, Cody RL, Hutchins GD, Mudgett EE. Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology. 1991;179:765-770.
7. 18F]FDG positron emission tomography in primary breast cancer: clinical relevance and practicability. Eur J Nucl Med. 1996;23:618-623.
8. Avril N, Dose J, Jnicke F, et al. Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. J Clin Oncol. 1996;14:1848-1857.
9. Nieweg OE, Kim EE, Wong WH, et al. Positron emission tomography with fluorine-18-deoxyglucose in the detection and staging of breast cancer. Cancer. 1993;71:3920-3925.
10. Adler LP, Crowe JP, al-Kaisi NK, Sunshine JL. Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology. 1993;187:743-750.
11. Adler LP, Faulhaber PF, Schnur KC, Al-Kasi NL, Shenk RR. Axillary lymph node métastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology. 1997;203:323-327.
12. Avril N, Dose J, Jnicke F, et al. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose. J Natl Cancer Inst. 1996;88:1204-1209.
13. Utech CI, Young CS, Winter PF. Prospective evaluation of fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry. Eur J Nucl Med. 1996;23:1588-1593.
14. Crippa F, Agresti R, Seregni E, et al. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8.
15. Shreve PD, Steventon RS, Deters EC, Kison PV, Gross MD, Wahl RL. Oncologic diagnosis with 2-[fluorine-18]fluoro-2-deoxy-D-glucose imaging: dual-head coincidence gamma camera versus positron emission tomographic scanner. Radiology. 1998;207:431-137.
16. Hoekstra OS, Van Lingen A, Ossenkoppele GJ, Golding R, Teule GJJ. Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography. Eur J Nucl Med. 1993;20:1214-1217.
17. Mukherji SK, Drane WE, Tart RP, Landau S, Mancuso AA. Comparison of thallium-201 and F-18 FDG SPECT uptake in squamous cell carcinoma of the head and neck. AJNR. 1994;15:1837-1842.
18. Martin WH, Delbeke D, Patton JA, et al. FDG-SPECT: correlation with FDG-PET. J Nucl Med. 1995;36:988-995.
19. Macfarlane DJ, Cotton L, Ackermann RJ, et al. Triple-head SPECT with 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology. 1995;194:425-429.
20. Holle LH, Trampert L, Lung-Kurt S, et al. Investigation of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT. J Nucl Med. 1996;37:615-622.
21. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[fluorine-18]fluoro-2-deoxy-D-glucose. Radiology. 1996;198:225-231.
22. Mukherji SK, Drane WE, Mancuso AA, Parsons JT, Mendenhall WM, Stringer S. Occult primary tumors of the head and neck: detection with 2-[F-18]fluoro-2-deoxy-D-glucose SPECT. Radiology. 1996;199:761-766.
23. 18F-fluorodeoxyglucose single-photon emission computed tomography. AJR. 1997;168:771-774.
24. Strauss LG, Conti PS. The application of PET in clinical oncology. J Nucl Med. 1991;32:623-648.
25. Rigo P, Kaschten BJ, Hustinx R, et al. Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med. 1996;23:1641-1674.
26. Cherry SR, Dahlbom M, Hoffman EJ. 3D PET using conventional multislice tomograph without septa. J Comput Assist Tomogr. 1991;15:655-668.
27. Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M. Whole-body positron emission tomography in clinical oncology: comparison between attenuationcorrected and uncorrected images. Eur J Nucl Med 1997;24:1091-1098.
28. Imran MB, Kubota K, Yamada S, et al. Lesion-to-background ratio in nonattenuation-corrected whole-body FDG PET images. J Nucl Med. 1998;39:1219-1223.
29. Hamberg LM, Hunter GJ, Alpert NM, Choi NC, Babich JW, Fischman AJ. The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification? J Nucl Med. 1994;35:1308-1312.